Doyle Mittie sold AVTX
May 5, 2026 · Form 4 insider transaction
Doyle Mittie sold 1,679 shares of Avalo Therapeutics, Inc. at $16.00 per share, a transaction worth $26.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,679
Price
$16.00
Total value
$26.9K
InsiderDoyle Mittie
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 5, 2026
Filing dateMay 7, 2026
Shares owned after3,622
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.